Dr. Spellman works at the boundaries of basic discovery and implementation science for cancer precision medicine. He broadly collaborates to develop and deploy new analytic approaches to improve outcomes for patients with, or at high risk for, cancer. Prior to joining UCLA Dr. Spellman was Professor of Molecular and Medical Genetics at Oregon Health Science University and a Special Assistant to the Deputy Director of the NCI.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.